Joint Programming Initiative

More Years, Better Lives

The Potential and Challenges of Demographic Change

Kelasto database
Kelasto

Topic
Social Systems and Welfare
Work and Productivity
Relevance for this Topic
Country Finland
URL
More Topics

Governance

Contact information

Johanna Aarnio
Social Insurance Institute (KELA) / Statistics department
KELA, PO Box 450
00101 Helsinki
Finland
Phone: +358 20 634 1335
Email: tilastot@kela.fi
Url: www.kela.fi/in/internet/suomi.nsf/alias/kelasto

Timeliness, transparency


Type of data


Registry

Type of Study


Data are collected on an annual basis.

Data gathering method

Registries

Type of data


Registry

Type of Study


Data are collected on an annual basis.

Data gathering method

Registries


Access to data

Conditions of access


The research plan must be approved by SII before the data can be used. Linkages to other registries require separate applications for permission.


Register data

Access to data

Conditions of access


The research plan must be approved by SII before the data can be used. Linkages to other registries require separate applications for permission.


Register data


Coverage


Data are collected annually.


The dataset provides data on: ·         Reimbursements for medical and pharmaceutical expenses ·         Sickness and disability allowances ·         Occupational health care ·         Rehabilitation allowances

Coverage


Data are collected annually.


The dataset provides data on: • Reimbursements for medical and pharmaceutical expenses • Sickness and disability allowances • Occupational health care • Rehabilitation allowances


Linkage


Linkages to other registries require separate applications for permission, possible to link using the unique personal identification number.

Linkage


Linkages to other registries require separate applications for permission, possible to link using the unique personal identification number.


Data quality

Data quality


Applicability


Strengths: KELA database is the major source of information on the consumption of pharmaceuticals. Volumes and types of (reimbursed) drug purchases can be used to approximate the use of various types of drugs. In addition, drug consumption information can be used to supplement the often incomplete comorbidity information in the national discharge register (especially in the case of chronic diseases, e.g. diabetes). Weaknesses: aggregated data; but individual level data can be obtained for research purposes.

Applicability


Strengths: KELA database is the major source of information on the consumption of pharmaceuticals. Volumes and types of (reimbursed) drug purchases can be used to approximate the use of various types of drugs. In addition, drug consumption information can be used to supplement the often incomplete comorbidity information in the national discharge register (especially in the case of chronic diseases, e.g. diabetes). Weaknesses: aggregated data; but individual level data can be obtained for research purposes.


  • The information about this dataset was compiled by the author:
  • Pasi Moisio
  • (see Partners)